Can a Medrol Dose‑Pak (methylprednisolone) cause hair loss?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Medrol Dose-Pak Cause Hair Loss?

No, methylprednisolone (Medrol Dose-Pak) is not listed as a cause of hair loss in the FDA drug label and is actually used as a treatment for certain types of hair loss, particularly alopecia areata. 1

Understanding the Relationship Between Corticosteroids and Hair

The FDA labeling for Medrol Dose-Pak does not include hair loss as a recognized adverse effect 1. In fact, corticosteroids like methylprednisolone are therapeutic agents for autoimmune hair loss conditions.

When Corticosteroids Are Used to TREAT Hair Loss

  • Systemic corticosteroids are commonly prescribed for acute or rapidly progressing alopecia areata 2
  • Oral betamethasone (a similar corticosteroid) mini-pulses achieve ≥50% hair regrowth in 62.5% of patients with moderate to severe alopecia areata 2
  • The mechanism works by reducing CD8+ T-cell-mediated immune attack on hair follicles 3

Important Distinction: Drug-Induced Hair Loss vs. Corticosteroid Effects

While many drugs can cause hair loss through telogen effluvium or anagen effluvium 4, 5, glucocorticoids like methylprednisolone are specifically noted to cause hypertrichosis (excessive hair growth) rather than hair loss 6. The research literature identifies glucocorticoids among drugs that produce hair growth, not hair loss 6.

Clinical Pitfalls to Avoid

Do not confuse temporal association with causation. If a patient develops hair loss while taking Medrol Dose-Pak, consider these alternative explanations:

  • The underlying condition being treated (inflammatory diseases, autoimmune conditions, severe illness)
  • Telogen effluvium triggers including fever, severe illness, stress, or the medical event that prompted corticosteroid use 4
  • Pre-existing androgenetic alopecia that may have coincidentally progressed
  • Other concurrent medications that are known hair loss culprits

What to Look For Instead

If hair loss occurs during Medrol Dose-Pak treatment, investigate:

  • The primary diagnosis requiring corticosteroid therapy
  • Recent physiologic stressors (illness, surgery, hospitalization) within 2-4 months prior 6
  • Other medications known to cause telogen effluvium (anticoagulants, retinoids, interferons, antihyperlipidemic drugs) 6
  • Thyroid dysfunction or nutritional deficiencies

The hair loss is almost certainly related to the underlying medical condition or other factors, not the methylprednisolone itself.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.